ING Group’s Inovio Pharmaceuticals INO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q3 | – | Sell |
-12,156
| Closed | -$429K | – | 614 |
|
|
2019
Q2 | $429K | Hold |
12,156
| – | – | 0.01% | 560 |
|
|
2019
Q1 | $544K | Buy |
12,156
+6,323
| +108% | +$283K | 0.01% | 435 |
|
|
2018
Q4 | $280K | Hold |
5,833
| – | – | 0.01% | 601 |
|
|
2018
Q3 | $389K | Buy |
+5,833
| New | +$389K | 0.01% | 592 |
|
|
2018
Q2 | – | Sell |
-5,833
| Closed | -$330K | – | 784 |
|
|
2018
Q1 | $330K | Hold |
5,833
| – | – | 0.01% | 588 |
|
|
2017
Q4 | $289K | Hold |
5,833
| – | – | ﹤0.01% | 657 |
|
|
2017
Q3 | $444K | Buy |
5,833
+4,166
| +250% | +$317K | 0.01% | 534 |
|
|
2017
Q2 | $157K | Sell |
1,667
-5,560
| -77% | -$524K | ﹤0.01% | 805 |
|
|
2017
Q1 | $574K | Hold |
7,227
| – | – | 0.01% | 423 |
|
|
2016
Q4 | $600K | Hold |
7,227
| – | – | 0.01% | 402 |
|
|
2016
Q3 | $803K | Hold |
7,227
| – | – | 0.01% | 315 |
|
|
2016
Q2 | $801K | Sell |
7,227
-1,666
| -19% | -$185K | 0.01% | 276 |
|
|
2016
Q1 | $928K | Sell |
8,893
-29,167
| -77% | -$3.04M | 0.01% | 299 |
|
|
2015
Q4 | $3.07M | Buy |
38,060
+29,135
| +326% | +$2.35M | 0.02% | 365 |
|
|
2015
Q3 | $618K | Sell |
8,925
-25,302
| -74% | -$1.75M | ﹤0.01% | 490 |
|
|
2015
Q2 | $3.35M | Buy |
34,227
+32,927
| +2,533% | +$3.22M | 0.02% | 404 |
|
|
2015
Q1 | $127K | Buy |
+1,300
| New | +$127K | ﹤0.01% | 777 |
|